News

A 60-year-old American company has been forced to turn its back on its traditional business model.
Despite their benefits, there are a number of things to consider before taking weight loss drugs – including possible ...
Microdosing isn’t just popular for psychedelics. Some consumers are taking smaller than standard doses of GLP-1s—the popular ...
It comes as the weight loss company had been struggling under $1.6billion (£1.2billion) of debt after losing business to ...
Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy as the U.S.
Since U.S. adult obesity rates have doubled since 1990 (from 21.2% in 1990 to 43.8% in 2022 for women, and 16.9% to 41.6% in ...
( ! ) Warning: Cannot modify header information - headers already sent by (output started at /ns02/www/vhosts/www3.farmersjournal.ie/2024-article.php:72) in ...
WeightWatchers filed for bankruptcy on Tuesday as Americans shunned its offerings in favor of Novo and Lilly drugs and copies from pharmacies that can cut a person's weight by as much as 20%.
At its peak, WeightWatchers was seen as being synonymous with safe and controlled weight loss. With 4.5million subscribers ...
The points-system-based weight loss program filed for bankruptcy on May 6 ... as people turn to popular medications like Ozempic, Mounjaro, and Wegovy. Originally used to treat diabetes, GLP ...
May 8, 2025, 7:01am CDT Updated: May 8, 2025, 8:00am CDT TMRW Tara Comonte, CEO of WW International WW International (NASDAQ: WW) has declared bankruptcy ... offer clinical weight loss solutions ...